INZY
Inozyme Pharma, Inc.
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Inozyme Pharma, Inc. (INZY) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
Showing 10 of 22 transactions (past 365 days)
| 2025-07-03 | 2025-07-01 | Hopfner Robert Lorne | Director | Tender Special | 2,923,110 | $4.00 | -$11,692,440 |
| 2025-07-03 | 2025-07-01 | Bolte Axel | Director | Disposition | 159,187 | $0.00 | $0 |
| 2025-07-03 | 2025-07-01 | Subramanian Sanjay | CFO | Tender Special | 39,701 | $4.00 | -$158,804 |
| 2025-07-03 | 2025-07-01 | Hopfner Robert Lorne | Director | Tender Special | 1,571,741 | $4.00 | -$6,286,964 |
| 2025-07-03 | 2025-07-01 | Subramanian Sanjay | CFO | Disposition | 180,000 | $0.00 | $0 |
| 2025-07-03 | 2025-07-01 | Bolte Axel | Director | Disposition | 234,176 | $0.00 | $0 |
| 2025-07-03 | 2025-07-01 | Winton Matthew | COO | Tender Special | 21,743 | $4.00 | -$86,972 |
| 2025-07-03 | 2025-07-01 | Subramanian Sanjay | CFO | Disposition | 135,000 | $0.00 | $0 |
| 2025-07-03 | 2025-07-01 | Winton Matthew | COO | Disposition | 145,000 | $0.00 | $0 |
| 2025-07-03 | 2025-07-01 | Subramanian Sanjay | CFO | Disposition | 145,000 | $0.00 | $0 |
INZY
Director
Tender Special
-$11.7M
Hopfner Robert Lorne2,923,110 shares @ $4.00
Filed 2025-07-03Trade 2025-07-01
INZY
CFO
Tender Special
-$158.8K
Subramanian Sanjay39,701 shares @ $4.00
Filed 2025-07-03Trade 2025-07-01
INZY
Director
Tender Special
-$6.3M
Hopfner Robert Lorne1,571,741 shares @ $4.00
Filed 2025-07-03Trade 2025-07-01
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.